The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, WNNR and Target on the Trade Date specified below. The term “Counterparty” refers to WNNR...Andretti Acquisition Corp. • March 26th, 2024 • Services-prepackaged software
Company FiledMarch 26th, 2024 IndustryThis Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, WNNR and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller and HNRA on the Trade Date specified below. The term “Counterparty” refers to HNRA. In...HNR Acquisition Corp. • November 3rd, 2023 • Crude petroleum & natural gas
Company FiledNovember 3rd, 2023 IndustryThis Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller and HNRA as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, GFOR and Target on the Trade Date specified below. The term “Counterparty” refers to GFOR...Graf Acquisition Corp. IV • September 29th, 2023 • Biological products, (no disgnostic substances)
Company FiledSeptember 29th, 2023 IndustryThis Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, GFOR and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, GFOR and Target on the Trade Date specified below. The term “Counterparty” refers to GFOR...Graf Acquisition Corp. IV • September 29th, 2023 • Biological products, (no disgnostic substances)
Company FiledSeptember 29th, 2023 IndustryThis Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, GFOR and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, OXAC and Target on the Trade Date specified below. The term “Counterparty” refers to OXAC...Oxbridge Acquisition Corp. • August 7th, 2023 • Air transportation, nonscheduled
Company FiledAugust 7th, 2023 IndustryThis Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, OXAC and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, Priveterra and Target on the Trade Date specified below. The term “Counterparty” refers to...AEON Biopharma, Inc. • July 27th, 2023 • Pharmaceutical preparations
Company FiledJuly 27th, 2023 IndustryThis Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, Priveterra and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, Priveterra and Target on the Trade Date specified below. The term “Counterparty” refers to...AEON Biopharma, Inc. • July 27th, 2023 • Pharmaceutical preparations
Company FiledJuly 27th, 2023 IndustryThis Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, Priveterra and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, Priveterra and Target on the Trade Date specified below. The term “Counterparty” refers to...Priveterra Acquisition Corp. • June 30th, 2023 • Pharmaceutical preparations
Company FiledJune 30th, 2023 IndustryThis Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, Priveterra and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.
The purpose of this agreement (this “Confirmation”) is to confirm the terms and conditions of the transaction (the “Transaction”) entered into between Seller, Priveterra and Target on the Trade Date specified below. The term “Counterparty” refers to...Priveterra Acquisition Corp. • June 30th, 2023 • Pharmaceutical preparations
Company FiledJune 30th, 2023 IndustryThis Confirmation, together with the Pricing Date Notices, evidences a complete binding agreement between Seller, Priveterra and Target as to the subject matter and terms of the Transaction to which this Confirmation relates and shall supersede all prior or contemporaneous written or oral communications with respect thereto.